Jasper Therapeutics Inc (JSPR) — Financial Flexibility Index
Jasper Therapeutics Inc (JSPR) has a Financial Flexibility Index of -0.82x as of March 2026. Free cash flow of $-14.55 Million (operating CF $-14.55 Million minus capex $0.00) represents -1% of total liabilities ($17.78 Million). Check Jasper Therapeutics Inc (JSPR) tangible net worth to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jasper Therapeutics Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Jasper Therapeutics Inc across 7 annual periods. For the full cash flow conversion analysis, see Jasper Therapeutics Inc cash flow conversion.
Annual Financial Flexibility Index for Jasper Therapeutics Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Jasper Therapeutics Inc. Explore Jasper Therapeutics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.44x | $-77.15 Million | $-77.16 Million | $31.63 Million | ▲ +28.4% |
| 2024 | -3.40x | $-62.05 Million | $-62.60 Million | $18.23 Million | ▼ -8.1% |
| 2023 | -3.15x | $-51.80 Million | $-52.07 Million | $16.45 Million | ▲ +14.0% |
| 2022 | -3.66x | $-45.28 Million | $-45.86 Million | $12.37 Million | ▼ -182.7% |
| 2021 | -1.29x | $-31.25 Million | $-33.68 Million | $24.14 Million | ▼ -378.1% |
| 2020 | -0.27x | $-15.84 Million | $-18.27 Million | $58.49 Million | ▼ -460.4% |
| 2019 | 0.08x | $459.00K | $-1.97 Million | $6.11 Million | — |